Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01317901 Org: User:
Start: 05/31/11 End: 06/30/13 Due: 06/30/14

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Phase: N/A Priority: Normal
NCT ID: NCT06634394 Org: User:
Start: 10/01/24 End: 03/31/28 Due: 03/31/29

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00614042 Org: User:
Start: 01/31/08 End: 03/31/12 Due: 03/31/13

ALG.APV-527 First-in-human Study

Phase: N/A Priority: Normal
NCT ID: NCT05934539 Org: User:
Start: 12/23/22 End: 12/01/25 Due: 12/01/26

Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

Phase: N/A Priority: Normal
NCT ID: NCT04973618 Org: User:
Start: 01/31/25 End: 01/31/27 Due: 01/31/28

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01188681 Org: User:
Start: 09/30/10 End: 12/31/14 Due: 12/31/15

Phase 1b Safety and Efficacy Study of TRU-016

Phase: N/A Priority: Normal
NCT ID: NCT01644253 Org: User:
Start: 09/30/12 End: 04/21/21 Due: 04/21/22

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03768219 Org: User:
Start: 03/18/19 End: 06/30/20 Due: 06/30/21

Study of ES414 in Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02262910 Org: User:
Start: 01/31/15 End: 02/18/19 Due: 02/18/20